Cymat Technologies Ltd.
CYMHF
$0.07
$0.00-5.00%
OTC PK
| 10/31/2025 | 07/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 29.76% | -13.09% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 29.76% | -13.09% | |||
| Cost of Revenue | -68.40% | -6.64% | |||
| Gross Profit | 150.39% | 0.53% | |||
| SG&A Expenses | 45.51% | -25.52% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.11% | -17.84% | |||
| Operating Income | 6.94% | 18.86% | |||
| Income Before Tax | 17.00% | 1.57% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 17.00% | 1.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 17.00% | 1.57% | |||
| EBIT | 6.94% | 18.86% | |||
| EBITDA | 17.42% | 18.97% | |||
| EPS Basic | 25.00% | 20.57% | |||
| Normalized Basic EPS | 24.64% | 25.00% | |||
| EPS Diluted | 25.00% | 20.57% | |||
| Normalized Diluted EPS | 24.64% | 25.00% | |||
| Average Basic Shares Outstanding | 10.90% | 24.06% | |||
| Average Diluted Shares Outstanding | 10.90% | 24.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||